We’ve come a long way in the fight against HIV/AIDS. Once a deadly terminal disease, AIDS is now categorized as a chronic disease. Thanks to the development of new treatments such as the anti-retroviral therapy (HAART) that have helped bring down the death rates dramatically. However, the fight is still far from over – In 2008, about 2.7 million people, including 430,000 children, were newly diagnosed with HIV and total twenty-five million have died since HIV/AIDS was identified in 1981.
To completely eradicate this disease, researchers are working tirelessly towards an HIV vaccine. You can help in the development of the vaccine by participating in a clinical study. Below are a few clinical studies listed on TrialX:
- A Phase I Trial to Evaluate Safety and Immunogenicity of Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
- Phase 1 Safety Study of Two Experimental HIV Vaccines
- Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
You can follow the directions on the trial page to identify the research site nearest to you and contact the investigator of the trial. Our goal at TrialX is to make the process of finding the right trial and contacting the investigator quick and painless.